Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab.

MLA

Castro, Januario E., et al. “Chronic Lymphocytic Leukemia Associated with Immunotactoid Glomerulopathy: A Case Report of Successful Treatment with High-Dose Methylprednisolone in Combination with Rituximab Followed by Alemtuzumab.” Leukemia & Lymphoma, vol. 53, no. 9, Sept. 2012, pp. 1835–38. EBSCOhost, https://doi.org/10.3109/10428194.2012.663914.

APA

Castro, J. E., Diaz-Perez, J. A., Barajas-Gamboa, J. S., Horton, J. M., Weidner, N., & Kipps, T. J. (2012). Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab. Leukemia & Lymphoma, 53(9), 1835–1838. https://doi.org/10.3109/10428194.2012.663914

Chicago

Castro, Januario E., Julio A. Diaz-Perez, Juan S. Barajas-Gamboa, John M. Horton, Noel Weidner, and Thomas J. Kipps. 2012. “Chronic Lymphocytic Leukemia Associated with Immunotactoid Glomerulopathy: A Case Report of Successful Treatment with High-Dose Methylprednisolone in Combination with Rituximab Followed by Alemtuzumab.” Leukemia & Lymphoma 53 (9): 1835–38. doi:10.3109/10428194.2012.663914.